Mantis Biotech
Infrastructure for human-in-computer models
About Mantis Biotech
We are building a unified biomedical device testing and regulatory platform that connects every stage of product development from CAD design through simulation, bench testing, and verification to FDA Q-Submissions.
Pitch deck breakdown
How Mantis Biotech would pitch themselves.
Target customer
Human-in-computer models — the core audience Mantis Biotech's product is built around.
Problem they solve
We are building a unified biomedical device testing and regulatory platform that connects every stage of product development from CAD design through simulation, bench testing, and verification to FDA Q-Submissions. The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Mantis Biotech differentiates on infrastructure for human-in-computer models. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Early-stage GTM — typically product-led growth (free tier or low-friction onboarding) paired with founder-led sales for the first 100 customers. Heavy content marketing + community presence on Twitter/X, LinkedIn, and category-specific Slack groups.
Mantis Biotech website preview
Company facts
- Category
- SaaS
- Funding stage
- Seed
- Total raised
- $0
- Founded
- 2020
- Team size
- 1–10
- HQ
- New York, United States
- Country
- United States
- Website
- mantisbiotech.com
Frequently asked questions
What does Mantis Biotech do?
We are building a unified biomedical device testing and regulatory platform that connects every stage of product development from CAD design through simulation, bench testing, and verification to FDA Q-Submissions.
Where is Mantis Biotech based?
Mantis Biotech is based in New York, United States, United States.
When was Mantis Biotech founded?
Mantis Biotech was founded in 2020.
How much has Mantis Biotech raised?
Mantis Biotech has raised $0 in their Seed round.